Anticonvulsant Effects of Fractions Isolated from Dinoponera quadriceps (Kempt) Ant Venom (Formicidae: Ponerinae)

• Published in: Toxins Vol. 9; no. 1; p. 5
• Main Authors: Nôga, Diana Aline Morais Ferreira, Brandão, Luiz Eduardo Mateus, Cagni, Fernanda Carvalho, Silva, Delano, de Azevedo, Dina Lilia Oliveira, Araújo, Arrilton, Dos Santos, Wagner Ferreira, Miranda, Antonio, da Silva, Regina Helena, Ribeiro, Alessandra Mussi
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.01.2017; MDPI
• Subjects: Animals; ant venom; Ant Venoms - chemistry; Ant Venoms - pharmacology; Anticonvulsants; Anticonvulsants - chemistry; Anticonvulsants - pharmacology; Ants; Bicuculline; Chromatography; Convulsions & seizures; Death; Dinoponera quadriceps; Disease Models, Animal; Drug therapy; Epilepsy; Formicidae; High performance liquid chromatography; Latency; Liquid chromatography; Male; Mass spectrometry; Mass spectroscopy; Mice; Molecular weight; Mortality; natural product; Natural products; neuroactive compounds; peptide fraction; Pharmacology; Quadriceps muscle; Seizing; Seizures; Seizures - chemically induced; Seizures - drug therapy; tonic-clonic seizures; Toxins; Venom; Ventricle; Ventricles (cerebral); neuroactive compounds; peptide fraction; tonic-clonic seizures; bicuculline; natural product; ant venom
• ISSN: 2072-6651; 2072-6651
• DOI: 10.3390/toxins9010005

Natural products, sources of new pharmacological substances, have large chemical diversity and architectural complexity. In this context, some toxins obtained from invertebrate venoms have anticonvulsant effects. Epilepsy is a neurological disorder that affects about 65 million people worldwide, and approximately 30% of cases are resistant to pharmacological treatment. Previous studies from our group show that the denatured venom of the ant (Kempt) protects mice against bicuculline (BIC)-induced seizures and death. The aim of this study was to investigate the anticonvulsant activity of compounds isolated from venom against seizures induced by BIC in mice. Crude venom was fractionated by high-performance liquid chromatography (HPLC) resulting in six fractions referred to as DqTx1-DqTx6. A liquid chromatography-mass spectrometry (LC/MS) analysis revealed a major 431 Da compound in fractions DqTx1 and DqTx2. Fractions DqTx3 and DqTx4 showed a compound of 2451 Da and DqTx5 revealed a 2436 Da compound. Furthermore, the DqTx6 fraction exhibited a major component with a molecular weight of 13,196 Da. Each fraction (1 mg/mL) was microinjected into the lateral ventricle of mice, and the animals were observed in an open field. We did not observe behavioral alterations when the fractions were given alone. Conversely, when the fractions were microinjected 20 min prior to the administration of BIC (21.6 nM), DqTx1, DqTx4, and DqTx6 fractions increased the latency for onset of tonic-clonic seizures. Moreover, all fractions, except DqTx5, increased latency to death. The more relevant result was obtained with the DqTx6 fraction, which protected 62.5% of the animals against tonic-clonic seizures. Furthermore, this fraction protected 100% of the animals from seizure episodes followed by death. Taken together, these findings indicate that compounds from ant venom might be a potential source of new anticonvulsants molecules.